Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies
Journal of Diabetes Investigation · 2024
DOI: 10.1111/jdi.14211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2024. Verfasst von Machiko Morita und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes and Metabolism, Koseiren Tsurumi Hospital, Oita, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Neuropathies, Nerve Conduction Studies, Neural Conduction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims/Introduction Although several studies have shown the association between continuous glucose monitoring (CGM)‐derived glycemic variability (GV) and diabetic peripheral neuropathy, no studies have focused on outpatients or used NC‐stat®/DPNCheck™, a new point‐of‐care device for nerve conduction study (NCS). We investigated the association between CGM‐derived GV and NCS using DPNCheck™ in outpatients with type 2 diabetes, and further analyzed the difference in results between patients with and without well‐controlled HbA1c levels. Materials and Methods All outpatients with type 2 diabetes using the CGM device (FreeStyle Libre Pro®) between 2017 and 2022 were investigated. Sural nerve conduction was evaluated by sensory nerve action potential (SNAP) amplitude and sensory conduction velocity (SCV) using DPNCheck™. Associations of CGM‐derived GV metrics with SNAP amplitude and SCV were investigated.
Results
In total, 304 outpatients with type 2 diabetes were included. In a linear regression model, most CGM‐derived GV metrics except for the mean amplitude of glucose excursion and low blood glucose index were significantly associated with SCV, but not with SNAP amplitude. The significant associations of most CGM‐derived GV metrics with SCV remained after adjustment for possible confounding factors, but not after adjustment for glycated hemoglobin (HbA1c). Most CGM‐derived GV metrics were significantly associated with SCV after adjustment for HbA1c in patients with a HbA1c ≤ 6.9%, but not in those with a HbA1c ≥ 7.0%.
Conclusions
In outpatients with type 2 diabetes, multiple CGM‐derived GV metrics were significantly associated with SCV obtained by DPNCheck™. GV may have independent impacts on peripheral nerve function, particularly in patients with well‐controlled HbA1c levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diabetes and Metabolism, Koseiren Tsurumi Hospital, Oita, Japan.
- Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.
ORCID-Profile: Machiko Morita, Kentaro Sada, Shuji Hidaka, Hirotaka Shibata
Zitieren
APA
Morita, M., Sada, K., Hidaka, S., Ogawa, M., & Shibata, H. (2024). Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14211
Vancouver
Morita M, Sada K, Hidaka S, Ogawa M, Shibata H. Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies. Journal of Diabetes Investigation. 2024. doi:10.1111/jdi.14211
BibTeX
@article{Morita2024,
author = {Morita, Machiko and Sada, Kentaro and Hidaka, Shuji and Ogawa, Miki and Shibata, Hirotaka},
title = {Glycemic variability is associated with sural nerve conduction velocity in outpatients with type 2 diabetes: Usefulness of a new point‐of‐care device for nerve conduction studies},
journal = {Journal of Diabetes Investigation},
year = {2024},
doi = {10.1111/jdi.14211}
}
EUVIMED